Aripiprazole as a dopamine partial agonist - Positive and negative effects

被引：9
|
作者：
Glick, ID [1 ]
Duggal, V
Hodulik, C
机构：
[1] Stanford Univ, Sch Med, Schizophrenia Res Serv, Stanford, CA 94305 USA
[2] Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2006年 / 26卷 / 01期
关键词：
D O I：
10.1097/01.jcp.0000196417.44847.0b
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 50 条
  • [31] AN EVALUATION OF THE PARTIAL DOPAMINE AGONIST TERGURIDE REGARDING POSITIVE SYMPTOMS REDUCTION IN SCHIZOPHRENICS
    OLBRICH, R
    SCHANZ, H
    [J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1991, 84 (03) : 233 - 236
  • [32] Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
    Burris, KD
    Molski, TF
    Xu, C
    Ryan, E
    Tottori, K
    Kikuchi, T
    Yocca, FD
    Molinoff, PB
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01): : 381 - 389
  • [33] The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa
    Frank, Guido K. W.
    Shott, Megan E.
    Hagman, Jennifer O.
    Schiel, Marissa A.
    DeGuzman, Marisa C.
    Rossi, Brogan
    [J]. INTERNATIONAL JOURNAL OF EATING DISORDERS, 2017, 50 (04) : 447 - 450
  • [34] Effects of Dopamine D2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-11C]DOPA
    Ito, Hiroshi
    Takano, Harumasa
    Arakawa, Ryosuke
    Takahashi, Hidehiko
    Kodaka, Fumitoshi
    Takahata, Keisuke
    Nogami, Tsuyoshi
    Suzuki, Masayuki
    Suhara, Tetsuya
    [J]. PLOS ONE, 2012, 7 (09):
  • [35] Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole
    Peterson, Evan
    Forlano, Rosaria
    [J]. AUSTRALASIAN PSYCHIATRY, 2017, 25 (06) : 614 - 616
  • [36] Adjunctive treatment with a dopamine partial agonist, aripiprazole, for anti psychotic-induced hyperprolactinemia: A placebo-controlled trial
    Shim, Joo-Cheol
    Shin, Jae-Goo K.
    Kelly, Deanna L.
    Jung, Do-Un
    Seo, Young-Soo
    Liu, Kwang-Hyeon
    Shon, Ji-Hong
    Conley, Robert R.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (09): : 1404 - 1410
  • [37] Partial agonists of dopamine receptors: clinical effects and dopamine receptor interactions in combining aripiprazole with a full antagonist in treating psychosis
    Cookson, John
    Pimm, Jonathan
    Reynolds, Gavin
    [J]. BJPSYCH ADVANCES, 2023, 29 (02) : 158 - 165
  • [38] Worsened agitation with aripiprazole: Adverse effect of dopamine partial agonism?
    DeQuardo, JR
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (01) : 132 - 133
  • [39] THE DOPAMINE D2 RECEPTOR PARTIAL AGONIST ARIPIPRAZOLE REDUCES ESCALATED ALCOHOL SELF-ADMINISTRATION IN DEPENDENT MICE
    Becker, H. C.
    Lopez, M. F.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 306A - 306A
  • [40] The dopamine-serotonin system stabilizer aripiprazole is a partial agonist at D2 and 5-HT1A receptors
    Jordan, S
    Robert, MD
    Frank, YD
    Tetsuro, K
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 183S - 183S
12345